Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
ASRS 2019 Street Team: Nancy M. Holekamp, MD
Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial
Nancy M. Holekamp, MD, discusses the take-home message from her presentation, “What Do the HARBOR Data Reveal About the Relationship Between the Drying of Subretinal and Intraretinal Fluid and Associated Vision Outcomes?”
Dr. Holekamp delivered her presentation at the 2019 annual meeting of the American Society of Retina Specialists in Chicago, on July 27, 2019.
Related Videos
Related Content
